Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.
$Palantir Technologies Inc.(PLTR)$$Hims & Hers Health Inc.(HIMS)$ ⚔️🤖💊 Palantir vs Hims. AI vs Healthcare. Which One Really Delivers? 💊🤖⚔️ In one corner we have $PLTR, the government backed AI titan with a cult following. In the other, $HIMS, the DTC health disruptor with explosive growth and a short interest fuse ready to blow. But let’s talk facts, not fandoms. 📈 Stock Performance (5Y): $PLTR up +1126% $HIMS up +290% That’s knockout territory for Palantir, but the deeper metrics tell a more surprising story. 🧠 Revenue Growth: $HIMS delivered stronger YoY expansion through 2022 and 2023. The curve is flattening now, but it still leads $PLTR in momentum. Advantage: HIMS 💸 Free Cash Flow Growth: In 20
$Palantir Technologies Inc.(PLTR)$$Hims & Hers Health Inc.(HIMS)$$Celanese(CE)$ 🔥📊🚨 Monday Movers: The Market’s Measuring Tape Is Out 🚨📊🔥 Today’s earnings call the shots, and the options market has spoken with some eye-popping implied moves. 🎯 Traders are bracing for double digit fireworks in names like: Hims & Hers ($HIMS) 16.50% Celanese ($CE) 13.30% Palantir ($PLTR) 12.10% TG Therapeutics ($TGTX) 12.00% Freshpet ($FRPT) 12.00% Fabrinet ($FN) 11.20% BioCryst ($BCRX) 10.20% BioNTech ($BNTX) 9.00% 🧠 The implied volatility tells us where the smart money is placing its bets. The spread between pricing and reality could create opportunity for both straddlers
$Hims & Hers Health Inc.(HIMS)$ 🔥📈🧨 $HIMS Is Heating Up. Bullish Breakout or Bear Trap? 🧨📈🔥 $HIMS is looking strong at these levels, and the setup is getting spicy heading into earnings! Short interest has now ballooned to 60.7 million shares, or 33 percent of the float, marking an all time high. That is not just bearish pressure, that is high octane squeeze fuel waiting for a spark. Technically, the chart is speaking loud and clear. We've broken out of the TrendCloud, reclaimed a solid demand zone that has held up since late 2023, and the 200MA is curling up beneath to offer additional support. Add to that the bullish momentum plus one of the most anticipated quarters in company history, and the bulls have the upper hand. But let’s be clear,